In subjects with hypertriglyceridemia, plasma concentrations of low density lipoprotein (LDL) 
Introduction
In humans, net cholesterol transport from the liver to the peripheral tissues seems to involve three plasma lipoprotein classes: very low density lipoproteins (VLDL; d 1.006 g/ml)', intermediate density lipoproteins (IDL; d 1.006-1.019 g/ml), and low density lipoproteins (LDL; d 1.019-1.063 g/ml). 60-70% of the total plasma cholesterol is found in the latter lipoprotein class in normolipidemic subjects. Several groups have studied the turnovers of these lipoproteins by using radiolabeled VLDL and following the radioactivity of the major structural protein, apoprotein B (apo B), in VLDL, IDI., and LDL. The results of these studies have suggested that VLDL enters the plasma from the liver and is converted to IDL and/or LDL as a result of intravascular catabolism (1) (2) (3) (4) . Furthermore, studies using both radiolabeled VLDL and LDL have suggested that in normal subjects, VLDL apo B is essentially the sole source of LDL apo B (5, 6) . In vitro studies using a variety of cultured cell systems have demonstrated that receptor-mediated binding and internalization of LDL play a significant role in the removal of these lipoproteins from plasma and the interstitial fluid (7) . In vivo studies using native and modified LDL tracers (8) (9) (10) confirmed the importance of receptor-mediated catabolism of LDL.
Based on the above observations, it seems that the plasma concentration of LDL cholesterol would be regulated by the rate of production of VLDL (which in turn would regulate the production of LDL) and/or the fractional catabolic rate (FCR) of LDL (8, (11) (12) (13) . Individuals with elevated plasma VLDL levels have increased production of both VLDL triglyceride and VLDL apo B (2) (3) (13) (14) (15) (16) (17) . It might be assumed, therefore, that plasma LDL levels would also be elevated in these subjbcts. However, they frequently have normal or even reduced plasma LDL cholesterol concentrations even though total plasma cholesterol levels are increased (18, 19) . Furthermore, when dietary (20, 21) or drug (21, 22 ) interventions reduce both VLbL production and plasma triglyceride levels, the concentration of plasma LDL cholesterol often increases. On the other hand, when high carbohydrate diets increase VLDL production, LDL concentrations fall (23) .
These observations in hypertriglyceridemic subjects under base-line conditions, and when VLDL production has been altered, are inconsistent with a simple regulatory system linking VLDL production to plasma LDL concentrations. Reduced conversion of VLDL apo B to LDL in hypertriglyceridemic subjects compared with normals (3, 5) could explain the data in the former group in the base-line state. However, Janus et al. (6) reported similar degrees of conversion of VLDL apo B to LDL in normal and hypertriglyceridemic individuals. In the only study of VLDL apo B metabolism before and after a perturbation, we demonstrated that the reciprocal changes in VLDL and LDL concentrations resulting from a high carbohydrate diet were associated with a reduction in the percent of VLDL apo B converted to LDL (4) . However, generation of LDL from sources other than VLDL and changes in the fractional catabolism of LDL could not be evaluated in that study. The possible importance of these factors is supported by data indicating both independent production (14, 24) and increased fractional catabolism (11, 13, 25) of LDL in hypertriglyceridemic subjects in the base-line state. In the present study we have used [3Hjglycerol, '3'I-VLDL, and '25I-LDL to simultaneously evaluate VLDL production, the conversion of VLDL to LDL, the sources of LDL, and the fractional catabolism of LDL before and after weight loss, a perturbation known to cause reciprocal changes in plasma VLDL and LDL concentrations. The results clearly demonstrate the complex nature of the regulation of LDL concentrations in subjects with hypertriglyceridemia.
Methods
Subjects. All subjects were males and were chosen because of the presence of hypertriglyceridemia and the absence of an elevated plasma LDL cholesterol concentration in a random fasting blood sample. All subjects had, therefore, the Type IV phenotype while consuming ad lib. diets (26) . The clinical characteristics of the group are depicted in Table I . The patients' ages ranged from 32 to 65 yr. Two of the hypertriglyceridemic subjects were within 20% of ideal body weight and four individuals were obese. There was a wide range of fasting plasma total triglyceride concentrations, while plasma total cholesterol levels were normal to slightly increased (27). Plasma high density lipoprotein cholesterol levels were uniformly reduced (27). None of the hypertriglyceridemic group had thyroid, renal, or hepatic dysfunction. Subject no. 2 had mild nonketotic diabetes mellitus treated with diet therapy. During the base-line study, his fasting plasma glucose concentrations were all < 150 mg/dl and his postprandial concentrations < 200 mg/dl. He had no glucosuria. After weight reduction, fasting and postprandial glucose levels were < 120 and 150 mg/dl, respectively. He was asymptomatic during both study periods. Subjects 1, 2, and 6 were receiving beta-blocking agents and/or thiazide drugs for hypertension and/or ischemic heart disease. These agents were administered in the same dose through both study periods. No subject had received any hypolipidemic agents for at least 2 mo before the base-line study.
Although the group was heterogeneous and probably represented the phenotypic expression of several genotypes, there was no attempt to characterize those genotypes because of the absence of any specific genotypic markers for the common hypertriglyceridemias. Attempts were made to identify known, specific abnormalities associated with hyperlipoproteinemia. Levels of lipoprotein and hepatic triglyceride lipase in postheparin plasma were measured in all subjects and were within the normal range (data not shown). All of the subjects had normal levels of apo CII. None of the subjects had a ratio of cholesterol to triglyceride in VLDL that was >0.35 and none were homozygous for apo E2. As noted above, there was no evidence for secondary hyperlipoproteinemias except in subject no. 2. In this subject, however, the severity of the hypertriglyceridemia was disproportionate to the mild degree of his hyperglycemia.
All studies were carried out with the subjects as inpatients in the General Clinical Research Center at The Mount Sinai School of Medicine, New York. Informed consent was obtained before each study. Each subject underwent a turnover study (see below) in the base-line state. Body weights had been stable for at least 8 wk before these studies. Post-weight reduction studies were carried out 3-6 mo after their base-line studies and after 4-10 wk of weight maintenance at their new reduced weight.
Protocol. After admission, subjects were given a solid food diet of 45% carbohydrate, 40% fat, and 15% protein with a polyunsaturated/ saturated fat ratio of 0.4, and 150 mg cholesterol per 1,000 kcal/d. Diet stabilization occurred over a 5-10-d period. There was usually some reduction in plasma triglyceride levels during the initial days of the stabilization period. After stabilization, plasma was obtained after an overnight fast for isolation of VLDL and LDL. 4 d later, subjects (32) . Gamma and beta radioactivity were measured in scintillation counters (Packard Instruments Co., Downers Grove, IL).
Cholesterol and triglyceride concentrations were measured by specific enzymatic methods using an ABA-100 analyzer (Abbott Laboratories, Chicago, IL). Lipoprotein cholesterol levels were determined after ultracentrifugation according to Lipid Research Clinic methodology (34) , except that dextran sulfate and MnCl2 were used to precipitate the lower density lipoproteins before measurement of high density lipoprotein cholesterol (35) . This method results in HDL cholesterol concentrations that are -10% lower than those obtained using the Lipid Research Clinic method.
Sodium dodecyl sulfate gel electrophoresis of VLDL and LDL in 3.5% acrylamide gels was performed according to the method of Krishnaiah et al. (36) . Agarose electrophoresis was carried out by the method of Noble (37) .
Quantitation of apo B in VLDL, IDL, and LDL was carried out using electroimmunoassay (38) (subjects 1-4) and radioimmunoassay (39) (subjects [5] [6] The series of curves describing the specific radioactivity of apo B in VLDL, IDL, and LDL generated by the injection of 13'I-VLDL are shown in Fig. 2 A. The present data were analyzed using apo B specific radioactivity in the three lipoprotein fractions and a nonlinear regression 
Results2
All subjects lost weight before their repeat studies (Table I) . For the group, the mean (± SD) percent ideal body weights were 132±17.9 at base line and 119±15.9 after weight reduction, P < 0.05. Table II presents the plasma VLDL triglyceride and apo B levels and the LDL cholesterol and apo B concentrations in the subjects during the base-line and post-weight reduction study periods. While they were consuming the baseline diet, both VLDL triglyceride and apo B concentrations were elevated in all of the subjects compared with normals that we have previously studied (43) . There was a wide range of values present for both variables. Compared to base line, weight loss resulted in reductions in both VLDL triglyceride (486.0±364.1 vs. 191.3±65.4 mg/dl, P < 0.05) and VLDL apo B levels (32.2±12.0 vs. 14.8±6.8 mg/dl, P < 0.05), although most individuals' concentrations were still elevated (Table II) .
The proportional reductions in triglyceride and apo B were, in general, similar.
The rate of production of VLDL triglyceride ranged from 17.7 to 119.7 mg/kg per h in the subjects during their baseline studies (Fig. 3) . The mean value for the group (56.6 ± 39.0 mg/kg per h) was markedly elevated compared with production rates for VLDL triglyceride reported for normal subjects in our laboratory (43) . Production rates diminished in all the subjects restudied after weight loss (mean, 28.6 + 23.1 mg/kg per h) and this reduction was significant; P < 0.05. However, (Fig. 4) . Again, the mean for the group (47.9 ± 41.4 mg/kg per d) was considerably higher than the value previously reported by our group for normal individuals (43) . When subjects were studied after weight loss, there was a marked reduction in the mean rate of VLDL apo B secretion for the group (19.0 ± 14.1 mg/kg per day, P < 0.05). Four of the six subjects had normal production rates for VLDL apo B after weight loss. A wide range of fractional catabolic rates for VLDL apo B (Table III) was present in the study group and the rates were reduced in five of the six subjects compared with our previously reported controls (43 In association with the elevated plasma levels and increased turnover of VLDL, the hypertriglyceridemic subjects had lownormal or reduced plasma levels of LDL cholesterol and LDL apo B (43) (Table II) . After weight loss, subjects demonstrated, in general, elevations in their plasma LDL cholesterol and apo B levels. Mean plasma LDL cholesterol was 64.0 ± 12.6 mg/dl during base line and 84.8 ± 24.9 mg/dl after weight loss, P < 0.05. Mean plasma LDL apo B concentrations were 58.4 ± 11.9 mg/dl and 69.5 ± 14.3 mg/dl during the same two study periods. The increase in LDL apo B was also significant; P < 0.05. Fig. 5 presents the rates of production of LDL apo B associated with the concentrations of LDL cholesterol and apo B described above. These estimates are derived from the LDL (43) . The LDL apo B FCR fell in five of the six patients after weight loss (Fig. 6) . The mean for the group at that time was 0.48 ± 0.1 d-'. This reduction in FCR after weight loss was significant (P < 0.05) and was associated with the increases in plasma LDL levels described above.
To determine the relationship between the changes observed in the turnover of VLDL apo B and those observed in the turnover of LDL apo B after weight loss, we used multicom- Fig. 2 B) . During the base-line period, the mean LDL apo B production rate partmental analysis to identify the sources of LDL production during each study. The results of this analysis, depicted in Fig.  7 , demonstrated two sources of LDL apo B production in these subjects. The rate of production of LDL apo B generated by the catabolism of VLDL apo B (hatched areas) was sufficient to account for the total rate of LDL apo B production in only one of the subjects during base line (No. 3). Thus, there seemed to be direct entry of LDL apo B into plasma (open area), during all but one of the base-line studies. After weight loss, while the absolute flux of LDL apo B generated by the catabolism of VLDL apo B fell in five of six subjects, direct secretion of LDL apo B increased in all six individuals (Table  IV) . These changes resulted in a reversal of the proportions of LDL apo B derived from VLDL and from direct production after weight reduction (Fig. 7) . In the six subjects, 73. Figure 7 . Percent of total LDL apo B production derived from either VLDL apo B (hatched area) or directly secreted LDL apo B (open area) in each subject pre-weight reduction (left bar of each pair) and post-weight reduction (right bar of each pair). All subjects, except no. 3 pre-weight loss, had LDL apo B that was secreted directly into plasma. After weight loss, the proportion of LDL derived from directly secreted particles increased in all subjects. These changes were significant for the group as a whole (P < 0.05). 
Discussion
It has been long observed that in spite of increased rates of VLDL production (2-4, 13-17), many subjects with hypertriglyceridemia have reduced plasma concentrations of LDL (18, 19) . It has also been demonstrated, by several investigators, that plasma VLDL and LDL concentrations change in a reciprocal fashion as a result of physiologic (20, 21, 23) and pharmacologic (21, 22) perturbations. Because plasma VLDL is the precursor of plasma LDL, it has been assumed that the degree of conversion of VLDL to LDL must be the key component in the regulation of plasma LDL concentration. Thus, reduced conversion of VLDL to LDL in hypertriglyceridemic subjects could result in low LDL levels, while an increase in that conversion concomitant with reduced VLDL levels would result in higher LDL concentrations. However, alternative explanations for the reciprocal relationship between VLDL and LDL exist. For example, the cholesterol content of LDL may be reduced in hypertriglyceridemic subjects (21) and the fractional catabolic rate for LDL apo B may be increased (13, 16, 25) . Finally, generation of LDL from sources other than VLDL, i.e., direct secretion of LDL (6, 14, 24, 44) , might also regulate steady-state plasma LDL concentrations. We have, therefore, used weight loss to investigate the regulation of plasma LDL concentrations in hypertriglyceridemic subjects at two different levels of plasma VLDL.
The results of these studies demonstrate the complexity of the regulatory system controlling the plasma concentration of LDL cholesterol. Although some heterogeneity did exist in this group of subjects who phenotypically had Type IV hyperlipoproteinemia, several general conclusions can be drawn relating the plasma concentrations of VLDL and LDL and the metabolism of those lipoproteins during the base-line state. First, in accord with reports from several laboratories (2) (3) (4) (13) (14) (15) (16) (17) the elevated plasma VLDL apo B and triglyceride levels present were associated with elevated rates of secretion of VLDL particles in all six subjects. Second, although <40% of the VLDL particles secreted under base-line conditions in our subjects were converted to LDL (3, 4, 6) , the production rates of LDL apo B were actually normal or elevated. These rates resulted, in part, from the high VLDL turnover rates. Thus, even though a small fraction of VLDL particles was converted to LDL, the absolute rate of flux of particles from VLDL to LDL was normal or high. The total flux of apo B into LDL was increased even further by direct entry of particles into plasma in the LDL density range in all but one of the six subjects during base line. Finally, in spite of normal or high input rates of LDL apo B, the steady-state plasma concentrations of LDL cholesterol and apo B were maintained at reduced or low-normal levels by both increased fractional catabolic rates of LDL apo B and a reduced cholesterol content of each LDL particle. Both of these abnormalities have been noted to occur in subjects with hypertriglyceridemia (1 1, 13, 14, 24, 25).
The alteration in lipoprotein metabolism associated with weight loss further illustrated the complex manner in which several metabolic variables interacted to regulate LDL cholesterol concentrations. First, the fall in VLDL levels to new steady-state concentrations after weight loss was associated with a fall in the secretion of VLDL into plasma in all six subjects. Although the percent conversion of VLDL apo B to LDL apo B increased in five of the six subjects, the fall in absolute VLDL apo B flux resulted in a reduction in the absolute amount of apo B entering the LDL density range from VLDL in five of the six individuals. However, while LDL production from VLDL was reduced, total LDL apo B production fell in only two of the six subjects because the flux of apo B directly into the LDL density range increased in all. In fact, in three subjects the predominant source of apo B in LDL after weight loss was independent of VLDL catabolism.
Finally, in parallel with the shift in the source of LDL apo B, two other factors critical to the regulation of the plasma LDL cholesterol level were also affected by weight loss. The FCR of LDL decreased in five of six subjects, and the ratio of cholesterol to protein in LDL increased in four of the six individuals.
One of the striking findings in our study was the demon- of Sf 12-60 particles in subjects fed high cholesterol diets. This mechanism may also be crucial in determining the phenotypic expression of the combined hyperlipoproteinemia genotype(s) in which elevated production of apo B may be the primary defect (16) .
The results of these kinetic studies, carried out using weight loss to allow quantitation of apo B flux at different plasma concentrations of VLDL and LDL, indicate that plasma LDL levels in hypertriglyceridemic subjects are regulated, to a large degree, by the fractional catabolic rate and the cholesterol content of that lipoprotein. An increased plasma VLDL pool can act as a "sink" for cholesterol esters transferred from LDL (47, 48) , and enrichment of LDL with cholesterol has been observed after weight loss, associated with reductions in VLDL levels (21 Finally, these studies point out the necessity of obtaining data related to the rate of lipoprotein transport before interpreting the clinical relevance of changes in static measurements. Thus, the rise in LDL cholesterol levels that occurs when VLDL triglyceride concentrations are reduced by various perturbations might lead an observer to question the clinical efficacy of such interventions. However, several investigators have suggested that the flux of LDL apo B may be an important risk factor for atherosclerosis (11, 51) , and LDL flux was either reduced or unchanged in our subjects after weight loss. Furthermore, total apo B turnover (VLDL plus LDL) was significantly reduced by weight reduction. Thus, the rise in plasma LDL levels after weight reduction may belie an improvement in lipoprotein metabolism that actually occurs. While the present studies do not provide data directly relevant to this issue of concentration versus flux, they make it clear that assessment of the clinical efficacy of measures that alter static plasma lipid concentrations may require data describing the changes in lipoprotein transport resulting from those interventions.
